Loading…
DIA Europe 2019 has ended
View analytic
Wednesday, February 6 • 09:15 - 10:15
#DMD8: EU Cooperation on HTA and beyond - Current Action and Future Developments

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session

With the confirmed participation of the European Commission, NICE, a Ministry of Health advisor and the coordination of EUCOPE, this panel discussion will provide a deep overview of EU Cooperation on HTA, namely on the centralisation of HTA assessment and the different stakeholders involved.

Chair

Alexander Natz, JD

Speaker

Panelist
Ana-Eva Ampelas, LLM

Panelist
Zoe Garrett

Panelist
Diane Kleinermans



Speakers
AA

Ana-Eva Ampelas

Head of Unit, Medical products: Quality, Safety, Innovation, European Commission
Anna-Eva Ampelas is Head of Unit for Medical Products: quality, safety, innovation in Unit B4 in DG SANTE, European Commission. In this capacity, she manages files on medicinal products (falsified medicines, clinical trials, shortages, GMP etc); Health Technology Assessments (HTA... Read More →
AN

Alexander Natz

Secretary General, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
Dr. Natz is Secretary General of the European Confederation of Pharmaceutical Entrepreneurs (www.eucope.org). From 2008-2013 he has been heading the Brussels Office of Bundesverband der Pharmazeutischen Industrie e.V. (BPI). Before, he has been a lawyer with Sträter Law Firm in Germany... Read More →
ZG

Zoe Garrett

SeniorTechnical Adviser – EUnetHTA, National Institute for Health and Care Excellence (NICE)
DK

Diane Kleinermans

Advisor, Ministry of Health and Social Affairs


Wednesday February 6, 2019 09:15 - 10:15
E2 Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria
  • Featured Topics Value and Access
  • Tags Session